Authors:
Williams, JC
Stone, D
Smith-Arica, JR
Morris, ID
Lowenstein, PR
Castro, MG
Citation: Jc. Williams et al., Regulated, adenovirus-mediated delivery of tyrosine hydroxylase suppressesgrowth of estrogen-induced pituitary prolactinomas, MOL THER, 4(6), 2001, pp. 593-602
Authors:
Zermansky, AJ
Bolognani, F
Stone, D
Cowsill, CM
Morrissey, G
Castro, MG
Lowenstein, PR
Citation: Aj. Zermansky et al., Towards global and long-term neurological gene therapy: Unexpected transgene dependent, high-level, and widespread distribution of HSV-1 thymidine kinase throughout the CNS, MOL THER, 4(5), 2001, pp. 490-498
Authors:
Thomas, CE
Birkett, D
Anozie, I
Castro, MG
Lowenstein, PR
Citation: Ce. Thomas et al., Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain, MOL THER, 3(1), 2001, pp. 36-46
Authors:
Umana, P
Gerdes, CA
Stone, D
Davis, JRE
Ward, D
Castro, MG
Lowenstein, PR
Citation: P. Umana et al., Efficient FLPe recombinase enables scalable production of helper-dependentadenoviral vectors with negligible helper-virus contamination, NAT BIOTECH, 19(6), 2001, pp. 582-585
Citation: Mg. Castro et al., Molecular therapy in a model neuroendocrine disease: developing clinical gene therapy for pituitary tumours, TRENDS ENDO, 12(2), 2001, pp. 58-64
Authors:
Thomas, CE
Schiedner, G
Kochanek, S
Castro, MG
Lowenstein, PR
Citation: Ce. Thomas et al., Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors, HUM GENE TH, 12(7), 2001, pp. 839-846
Authors:
Glaser, T
Castro, MG
Lowenstein, PR
Weller, M
Citation: T. Glaser et al., Death receptor-independent cytochrome c release and caspase activation mediate thymidine kinase plus ganciclovir-mediated cytotoxicity in LN-18 and LN-229 human malignant glioma cells, GENE THER, 8(6), 2001, pp. 469-476
Citation: Tc. Maleniak et al., Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell deathin primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU, CANC GENE T, 8(8), 2001, pp. 589-598
Citation: Pr. Lowenstein et Mg. Castro, Genetic engineering within the adult brain: Implications for molecular approaches to behavioral neuroscience, PHYSL BEHAV, 73(5), 2001, pp. 833-839
Authors:
Pariente, N
Sierra, S
Lowenstein, PR
Domingo, E
Citation: N. Pariente et al., Efficient virus extinction by combinations of a mutagen and antiviral inhibitors, J VIROLOGY, 75(20), 2001, pp. 9723-9730
Authors:
Smith-Arica, JR
Williams, JC
Stone, D
Smith, J
Lowenstein, PR
Castro, MG
Citation: Jr. Smith-arica et al., Switching on and off transgene expression within lactotrophic cells in theanterior pituitary gland in vivo, ENDOCRINOL, 142(6), 2001, pp. 2521-2532
Authors:
Davis, JRE
McVerry, J
Lincoln, GA
Windeatt, S
Lowenstein, PR
Castro, MG
McNeilly, AS
Citation: Jre. Davis et al., Cell type-specific adenoviral transgene expression in the intact ovine pituitary gland after stereotaxic delivery: An in vivo system for long-term multiple parameter evaluation of human pituitary gene therapy, ENDOCRINOL, 142(2), 2001, pp. 795-801
Citation: Td. Southgate et al., Long-term transgene expression within the anterior pituitary gland in situ: Impact on circulating hormone levels, cellular and antibody-mediated immune responses, ENDOCRINOL, 142(1), 2001, pp. 464-476
Authors:
Kingston, PA
Sinha, S
David, A
Castro, MG
Lowenstein, PR
Heagerty, AM
Citation: Pa. Kingston et al., Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition, CIRCULATION, 104(21), 2001, pp. 2595-2601
Authors:
Smith-Arica, JR
Morelli, AE
Larregina, AT
Smith, J
Lowenstein, PR
Castro, MG
Citation: Jr. Smith-arica et al., Cell-type-specific and regulatable transgenesis in the adult brain: Adenovirus-encoded combined transcriptional targeting and inducible transgene expression, MOL THER, 2(6), 2000, pp. 579-587
Citation: Ca. Gerdes et al., Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo (vol2, pg 330, 2000), MOL THER, 2(6), 2000, pp. 660-660
Citation: Ca. Gerdes et al., Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo, MOL THER, 2(4), 2000, pp. 330-338
Authors:
Cowsill, C
Southgate, TD
Morrissey, G
Dewey, RA
Morelli, AE
Maleniak, TC
Forrest, Z
Klatzmann, D
Wilkinson, GWG
Lowenstein, PR
Castro, MG
Citation: C. Cowsill et al., Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicityof a truncated HSV1-TK, GENE THER, 7(8), 2000, pp. 679-685
Authors:
Brown, O
Cowen, RL
Preston, CM
Castro, MG
Lowenstein, PR
Citation: O. Brown et al., Subcellular post-transcriptional targeting: delivery of an intracellular protein to the extracellular leaflet of the plasma membrane using a glycosyl-phosphatidyl inositol (GPI) membrane anchor in neurons and polarised epithelial cells, GENE THER, 7(22), 2000, pp. 1947-1953
Authors:
Thomas, CE
Schiedner, G
Kochanek, S
Castro, MG
Lowenstein, PR
Citation: Ce. Thomas et al., Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but notwith high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases, P NAS US, 97(13), 2000, pp. 7482-7487